Page last updated: 2024-10-28

beta-thujaplicin and Colonic Neoplasms

beta-thujaplicin has been researched along with Colonic Neoplasms in 2 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, YS1
Choi, KM1
Kim, W1
Jeon, YS1
Lee, YM1
Hong, JT1
Yun, YP1
Yoo, HS1
Seo, JS1
Choi, YH1
Moon, JW1
Kim, HS1
Park, SH1

Other Studies

2 other studies available for beta-thujaplicin and Colonic Neoplasms

ArticleYear
Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment.
    Journal of natural products, 2013, Dec-27, Volume: 76, Issue:12

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Colonic Neoplasms; Genes, bcl-2; HCT116 Cells; Humans; I

2013
Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
    BMC cell biology, 2017, 02-27, Volume: 18, Issue:1

    Topics: 5-Methylcytosine; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neo

2017